Interim Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2017	Sep. 30, 2016
Current assets:
Cash and cash equivalents	$ 532,508	$ 516,112
Restricted cash	5,752	3,645
Short-term investments	194,997	121,629
Accounts receivable, net of allowance for doubtful accounts of $3,258 and $2,370	88,216	75,688
Inventories	17,697	16,354
Prepaid expenses and other current assets	32,501	26,302
Total current assets	871,671	759,730
Long-term investments	326,800	393,904
Property, plant and equipment, net	471,095	443,656
Intangible assets, net	203,723	215,342
Goodwill	308,751	309,616
Deferred taxes	176,288	166,790
Other non-current assets	29,469	21,068
Total assets	2,387,797	2,310,106
Current liabilities:
Accounts payable	10,062	17,544
Accrued liabilities	179,029	169,055
Income taxes payable	25	2,304
Deferred revenue	23,940	24,180
Total current liabilities	213,056	213,083
Long-term deferred revenue	35,651	35,366
Other non-current liabilities	95,932	82,922
Total liabilities	344,639	331,371
Stockholders' equity:
Additional paid-in capital	37,459	42,032
Retained earnings	2,013,790	1,938,320
Accumulated other comprehensive (loss)	(14,708)	(10,197)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,036,642	1,970,256
Controlling interest	6,516	8,479
Total stockholders’ equity	2,043,158	1,978,735
Total liabilities and stockholders’ equity	2,387,797	2,310,106
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 57,702,863 shares issued and outstanding at March 31, 2017 and 57,018,362 at September 30, 2016
Stockholders' equity:
Common stock	57	57
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 44,073,597 shares issued and outstanding at March 31, 2017 and 44,403,847 at September 30, 2016
Stockholders' equity:
Common stock	$ 44	$ 44